Publications by authors named "Petr Pavlicek"

Claim this Profile
T
Treatment Patterns and Outcomes in Over 2200 Newly Diagnosed Multiple Myeloma Patients: Supporting Bortezomib-Lenalidomide-Dexamethasone as a Preferred Regimen in the Absence of Anti-CD38 Antibodies.
Alexandra Jungova, Martin Stork, Ivan Spicka, Jakub Radocha, Jiri Minarik, Petr Pavlicek

Clin Lymphoma Myeloma Leuk· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group.
Jiri Minarik, Ludek Pour, Vojtech Latal, Tomas Jelinek, Jan Straub, Petr Pavlicek

BMC Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma.
Sosana Delimpasi, Meletios A Dimopoulos, Jan Straub, Argiris Symeonidis, Luděk Pour

Am J Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Acute Kidney Injury in Children as a Rare Complication of Paroxysmal Cold Hemoglobinuria.
Jakub Zieg, Eva Flachsová, Eva Linhartová, Patrik Konopásek, Šárka Štolbová

J Pediatr Hematol Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies.
Viera Sandecka, Tereza Popkova, Martin Stork, Vladimir Maisnar, Jiri Minarik, Petr Pavlicek

Blood Cancer J· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysis.
Martin Stork, Ivan Spicka, Jakub Radocha, Jiri Minarik, Tomas Jelinek, Petr Pavlicek

Ann Hematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data.
Viera Sandecka, Luděk Pour, Ivan Špička, Jiří Minařík, Jakub Radocha

Neoplasma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas.
Martin Stork, Sabina Sevcikova, Tomas Jelinek, Jiri Minarik, Jakub Radocha, Petr Pavlicek

Biomedicines· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy.
Jiri Minarik, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomas Jelinek, Petr Pavlicek

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of patients at high risk of secondary extramedullary multiple myeloma development.
Martin Stork, Sabina Sevcikova, Jiri Minarik, Petra Krhovska, Jakub Radocha, Petr Pavlicek

Br J Haematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited efficacy of daratumumab in multiple myeloma with extramedullary disease.
Tomas Jelinek, Tereza Sevcikova, David Zihala, Tereza Popkova, Veronika Kapustova, Petr Pavlicek

Leukemia· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation.
Jakub Radocha, Tomas Jelinek, Ludek Pour, Ivan Spicka, Jiri Minarik, Petr Pavlicek

Int J Lab Hematol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data.
Viera Sandecká, Luděk Pour, Ivan Špička, Jiří Minařík, Jakub Radocha

Eur J Haematol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice.
Jiri Minarik, Tomas Pika, Jakub Radocha, Alexandra Jungova, Jan Straub, Petr Pavlicek

BMC Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapidly progressing acute myeloid leukemia with KAT6A-LEUTX fusion in a newborn.
Lucie Sramkova, Jana Cermakova, Katarina Kutkova, Zuzana Zemanova, Petr Pavlicek

Pediatr Blood Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Various phenotypes of disease associated with mutated DGKE gene.
Martin Bezdíčka, Petr Pavlíček, Květa Bláhová, Jaromír Háček, Jakub Zieg

Eur J Med Genet· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19.
Adam Klocperk, Zuzana Parackova, Jitka Dissou, Hana Malcova, Petr Pavlicek

Front Immunol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters: the Czech Myeloma Group model.
Roman Hájek, Viera Sandecka, Ivan Špička, Marc Raab, Hartmut Goldschmidt

Br J Haematol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selected Genetic Polymorphisms Associated with Hypoxia and Multidrug Resistance in Monoclonal Gammopathies Patients.
Martina Almasi, Lenka Besse, Lucie Brozova, Jiří Jarkovsky, Renata Bezdekova

Klin Onkol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies.
Jakub Radocha, Vladimír Maisnar, Luděk Pour, Ivan Špička, Jiři Minařík

Cancer Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous bortezomib in multiple myeloma patients induces similar therapeutic response rates as intravenous application but it does not reduce the incidence of peripheral neuropathy.
Jiri Minarik, Petr Pavlicek, Ludek Pour, Tomas Pika, Vladimir Maisnar

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentered patient-based evidence of the role of free light chain ratio normalization in multiple myeloma disease relapse.
Jakub Radocha, Luděk Pour, Tomáš Pika, Vladimír Maisnar, Ivan Špička

Eur J Haematol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous Heparinoids May Cause Bleeding in Mucor Infection and can be Detected by Nonactivated Thromboelastometry and Treated by Recombinant Activated Factor VII: A Case Report.
Miroslav Durila, Petr Pavlicek, Ivana Hadacova, Jiri Nahlovsky, Daniela Janeckova

Medicine (Baltimore)· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
10 years of experience with thalidomide in multiple myeloma patients: report of the Czech Myeloma Group.
Jiri Minarik, Viera Sandecka, Vladimir Maisnar, Evzen Gregora, Ivan Spicka, Petr Pavlicek

Leuk Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first case of fatal pneumonia caused by Panton-Valentine leukocidin-producing Staphylococcus aureus in an infant in the Czech Republic.
Helena Ambrozova, Vilma Maresova, Martin Fajt, Petr Pavlicek, Hana Rohacova

Folia Microbiol (Praha)· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis